ACE2, a New Regulator of the Renin Angiotensin System
ACE2,肾素血管紧张素系统的新型调节剂
基本信息
- 批准号:nhmrc : 268914
- 负责人:
- 金额:$ 32.85万
- 依托单位:
- 依托单位国家:澳大利亚
- 项目类别:NHMRC Project Grants
- 财政年份:2004
- 资助国家:澳大利亚
- 起止时间:2004-01-01 至 2006-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Angiotensin converting enzyme (ACE) is a key enzyme in the renin-angiotensin system (RAS), converting Angiotensin I to the potent vasoconstrictor Angiotensin II (Ang II). ACE inhibitors have been highly successful in the management of hypertension, are standard therapy following myocardial infarction to delay the development of heart failure, and also reduce the rate of progression of renal disease. Recently, a novel enzyme called ACE2 has been discovered in the heart and kidneys. Unlike ACE, ACE2 causes the formation of the vasodilator, Ang 1-7. We have data in the heart and the kidney that supports the concept that ACE2 acts in a counter-regulatory manner to ACE. We suggest that ACE2 may play an important role to modulate the balance between vasoconstrictors and vasodilators in the heart and kidney. The studies detailed in this proposal are designed to specifically examine the role and regulation of ACE2 in the healthy heart and kidney as well as in cardiovascular and renal disease. The project brings together two groups with complementary skills and techniques, both of whom have collaborations with the discoverers of ACE2, and who have been exploring the role of ACE2 as evidenced from our recent publication (Tikellis et al, Hypertension in press, 2003).
血管紧张素转化酶(ACE)是血管紧张素-血管紧张素系统(RAS)中的关键酶,将血管紧张素I转化为强效血管收缩剂血管紧张素II(Ang II)。ACE抑制剂在高血压的管理中非常成功,是心肌梗死后延迟心力衰竭发展的标准治疗,也降低了肾脏疾病的进展速度。最近,在心脏和肾脏中发现了一种名为ACE 2的新酶。与ACE不同,ACE 2导致血管扩张剂Ang 1-7的形成。我们在心脏和肾脏中的数据支持ACE 2以反调节方式对ACE起作用的概念。提示ACE 2可能在调节心脏和肾脏血管收缩和舒张的平衡中起重要作用。本提案中详述的研究旨在专门研究ACE 2在健康心脏和肾脏以及心血管和肾脏疾病中的作用和调节。该项目汇集了两个具有互补技能和技术的小组,这两个小组都与ACE 2的发现者合作,并且他们一直在探索ACE 2的作用,正如我们最近的出版物所证明的那样(Tikellis等人,Hypertension in press,2003)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Prof Alexander Smith其他文献
Prof Alexander Smith的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Prof Alexander Smith', 18)}}的其他基金
Imaging and Therapy Beamline (Synchrotron)
成像和治疗光束线(同步加速器)
- 批准号:
nhmrc : 606959 - 财政年份:2009
- 资助金额:
$ 32.85万 - 项目类别:
NHMRC Enabling Grants
Melanocortin Regulation of Reproduction
黑皮质素对生殖的调节
- 批准号:
nhmrc : 545918 - 财政年份:2009
- 资助金额:
$ 32.85万 - 项目类别:
NHMRC Project Grants
Research Fellowship - Grant ID:384177
研究奖学金 - 拨款 ID:384177
- 批准号:
nhmrc : 384177 - 财政年份:2006
- 资助金额:
$ 32.85万 - 项目类别:
NHMRC Research Fellowships
Regulation of Endothelin Converting Enzyme Subcellular Distribution and Vascular Endothelin Production.
内皮素转换酶亚细胞分布和血管内皮素产生的调节。
- 批准号:
nhmrc : 268913 - 财政年份:2004
- 资助金额:
$ 32.85万 - 项目类别:
NHMRC Project Grants
Arresting type 1 angiotensin receptors
抑制 1 型血管紧张素受体
- 批准号:
nhmrc : 268925 - 财政年份:2004
- 资助金额:
$ 32.85万 - 项目类别:
NHMRC Project Grants
Uncoupled Research Fellowship
解耦研究奖学金
- 批准号:
nhmrc : 182814 - 财政年份:2002
- 资助金额:
$ 32.85万 - 项目类别:
NHMRC Research Fellowships
相似海外基金
Characterising a new regulator of the Hedgehog pathway
表征 Hedgehog 通路的新调节因子
- 批准号:
DP240101935 - 财政年份:2024
- 资助金额:
$ 32.85万 - 项目类别:
Discovery Projects
Function of nitric oxide as a new growth regulator of red tide algae
一氧化氮作为新型赤潮藻生长调节剂的作用
- 批准号:
22K19213 - 财政年份:2022
- 资助金额:
$ 32.85万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
CAPER, a New Regulator of DNA Damage and Repair in Triple Negative Breast Cancer
CAPER,三阴性乳腺癌 DNA 损伤和修复的新调节剂
- 批准号:
10359895 - 财政年份:2022
- 资助金额:
$ 32.85万 - 项目类别:
Studies of a new checkpoint regulator in the control of intestinal inflammation
控制肠道炎症的新检查点调节剂的研究
- 批准号:
10271880 - 财政年份:2021
- 资助金额:
$ 32.85万 - 项目类别:
New role(s) for IRF5 as a regulator of tau accumulation in Alzheimer’s disease
IRF5 在阿尔茨海默病中调节 tau 蛋白积累的新作用
- 批准号:
10302599 - 财政年份:2021
- 资助金额:
$ 32.85万 - 项目类别:
A new mechanism of tissue fibrosis - a small peptide regulator of the TGF-beta1/Smad pathway
组织纤维化的新机制——TGF-β1/Smad通路的小肽调节剂
- 批准号:
nhmrc : 2003019 - 财政年份:2021
- 资助金额:
$ 32.85万 - 项目类别:
Ideas Grants
Studies of a new checkpoint regulator in the control of intestinal inflammation
控制肠道炎症的新检查点调节剂的研究
- 批准号:
10621272 - 财政年份:2021
- 资助金额:
$ 32.85万 - 项目类别:
The Th17 Master Regulator RORC2 as a New Target for HIV Immune Therapy and Cure Strategy
Th17 主调节因子 RORC2 作为 HIV 免疫治疗和治愈策略的新靶点
- 批准号:
444098 - 财政年份:2021
- 资助金额:
$ 32.85万 - 项目类别:
Operating Grants
Investigating a new regulator of cardiac rhythm in development and disease
研究发育和疾病中心律的新调节器
- 批准号:
nhmrc : 2004460 - 财政年份:2021
- 资助金额:
$ 32.85万 - 项目类别:
Ideas Grants
Mechanistic characterization of a new master regulator of cardiac virus infections
心脏病毒感染新主调节因子的机制表征
- 批准号:
10255819 - 财政年份:2020
- 资助金额:
$ 32.85万 - 项目类别: